EFFECT OF 2 INDIRECTLY ACTING DOPAMINE AGONISTS ON PROLACTIN SECRETION IN NORMOPROLACTINEMIC AND HYPERPROLACTINEMIC SUBJECTS - COMPARISON WITH THE EFFECT OF NOMIFENSINE

被引：10
|
作者：
CAMANNI, F
GENAZZANI, AR
DELEO, V
MOLINATTI, GM
CAMPAGNOLI, C
COCCHI, D
MULLER, EE
机构：
[1] UNIV MILAN,DEPT PHARMACOL,I-20129 MILAN,ITALY
[2] UNIV TURIN,CHAIRS METAB DIS & ENDOCRINOL,I-10126 TURIN,ITALY
[3] UNIV SIENA,CHAIR OBSTET PATHOL,I-53100 SIENA,ITALY
[4] UNIV CAGLIARI,CHAIR OBSTET PATHOL,I-09100 CAGLIARI,ITALY
[5] ST ANNA GYNECOLOG HOSP,TURIN,ITALY
来源：
NEUROENDOCRINOLOGY | 1981年 / 33卷 / 05期
关键词：
D O I：
10.1159/000123249
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：300 / 305
页数：6
相关论文
共 50 条
  • [21] EFFECT OF DOMPERIDONE ON PROLACTIN SECRETION IN HEALTHY-SUBJECTS
    UBERTI, ECD
    TRASFORINI, GC
    MARGUTTI, AR
    SAMMAROLI, SR
    PANMINERVA MEDICA, 1980, 22 (01) : 13 - 15
  • [22] EFFECT OF BENZAMIDE DRUGS ON PROLACTIN SECRETION - RELATION TO THE DOPAMINE RECEPTOR
    MELTZER, HY
    SO, R
    FANG, VS
    ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY, 1982, 35 : 61 - 82
  • [23] THE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON PROLACTIN RESPONSES IN NORMAL AND HYPERPROLACTINEMIC SUBJECTS
    ANDERSON, PW
    MALARKEY, WB
    SALK, J
    KLETSKY, OA
    HSUEH, WA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (03): : 518 - 522
  • [24] DIFFERENTIAL-EFFECTS OF DIRECT AND INDIRECTLY ACTING CHOLINERGIC AGONISTS ON GROWTH-HORMONE RELEASE IN MAN, AND LACK OF EFFECT ON CORTISOL SECRETION
    CASANUEVA, FF
    VILLANUEVA, L
    CORDIDO, F
    DIAZ, Y
    CABRANES, JA
    SPIEGEL, R
    DIEGUEZ, C
    JOURNAL OF NEUROENDOCRINOLOGY, 1989, 1 (05) : 379 - 382
  • [25] DOSE-RELATED PROLACTIN INHIBITORY EFFECT OF THE NEW LONG-ACTING DOPAMINE RECEPTOR AGONIST CABERGOLINE IN NORMAL CYCLING, PUERPERAL, AND HYPERPROLACTINEMIC WOMEN
    MELIS, GB
    GAMBACCIANI, M
    PAOLETTI, AM
    BENEVENTI, F
    MAIS, V
    BAROLDI, P
    FIORETTI, P
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (03): : 541 - 545
  • [26] LONG-LASTING PROLACTIN-LOWERING EFFECT OF CABERGOLINE, A NEW DOPAMINE AGONIST, IN HYPERPROLACTINEMIC PATIENTS
    FERRARI, C
    BARBIERI, C
    CALDARA, R
    MUCCI, M
    CODECASA, F
    PARACCHI, A
    ROMANO, C
    BOGHEN, M
    DUBINI, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (04): : 941 - 945
  • [27] THE EFFECT OF INTRASTRIATAL APPLICATION OF DIRECTLY AND INDIRECTLY ACTING DOPAMINE AGONISTS AND ANTAGONISTS ON THE INVIVO RELEASE OF ACETYLCHOLINE MEASURED BY BRAIN MICRODIALYSIS - THE IMPORTANCE OF THE POSTSURGERY INTERVAL
    DEBOER, P
    DAMSMA, G
    SCHRAM, Q
    STOOF, JC
    ZAAGSMA, J
    WESTERINK, BHC
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1992, 345 (02) : 144 - 152
  • [28] EFFECT OF DOPAMINE INFUSION ON SERUM PROLACTIN CONCENTRATION IN NORMAL AND HYPERPROLACTINAEMIC SUBJECTS
    RESCHINI, E
    FERRARI, C
    PERACCHI, M
    FADINI, R
    MESCHIA, M
    CROSIGNANI, PG
    CLINICAL ENDOCRINOLOGY, 1980, 13 (06) : 519 - 523
  • [29] EFFECT OF DOPAMINE AGONISTS AND ANTAGONISTS ON PARATHYROID-HORMONE AND CALCITONIN SECRETION
    KUKREJA, SC
    WILLIAMS, GA
    SETHI, R
    SHANMUGAM, A
    HARGIS, GK
    CLINICAL RESEARCH, 1982, 30 (04): : A780 - A780
  • [30] EFFECT OF SELECTIVE SEROTONIN RECEPTOR AGONISTS ON PROLACTIN SECRETION IN MALE-RATS
    JORGENSEN, H
    KNIGGE, U
    WARBERG, J
    NEUROENDOCRINOLOGY, 1993, 57 (03) : 401 - 407
12345